Florida Cancer Specialists South Region — Fort Myers, Florida

Florida Cancer Specialists South Region is a clinical research site located in Fort Myers, Florida, United States 33901.

Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.

Florida Cancer Specialists South Region has participated in 6 clinical trials with 1 currently active.

Therapeutic areas: Acute Myeloid Leukemia, Metastatic Colorectal Adenocarcinoma, HER2-positive Breast Cancer.

Sponsors: Seagen Inc., Seagen, a wholly owned subsidiary of Pfizer, Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fort Myers

Browse all research sites in Florida · View every site in Fort Myers

Sponsor Feasibility Report

Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Florida Cancer Specialists South Region?

Florida Cancer Specialists South Region has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Florida Cancer Specialists South Region conducted?

Florida Cancer Specialists South Region has 6 clinical trials on record, with 1 currently active. Their work covers Acute Myeloid Leukemia, Metastatic Colorectal Adenocarcinoma, HER2-positive Breast Cancer.

Is Florida Cancer Specialists South Region accredited by Crixeo Clinical Trials?

Florida Cancer Specialists South Region has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Florida Cancer Specialists South Region?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.